RxDoctor Payments Data

Proddutur Reddy, MD

Interventional Cardiology · Chicago, ILNPI 1184712481

Payments from drug & device makers

$698in general payments, 2019–2025

Across 23 payments — averaging $30.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$283
  • Terumo Medical Corporation$160
  • Inari Medical, Inc.$63
  • Cardinal Health 200 LLC$45
  • Novartis$29
  • Abbott$28
  • plus $91 from 5 others

What the payments were for

  • Food & beverage$698100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$698 in reported general payments places this provider in the 10th percentile of 303 interventional cardiology providers in Illinois.

See all interventional cardiology providers in Illinois

Medicare billing

Part B allowed, 2024
$164,783
Medicare patients
525
Services billed
1,243

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Repatha SureclickEvolocumab194$235,494
EliquisApixaban86$123,627
EntrestoSacubitril/Valsartan57$72,276
Praluent PenAlirocumab34$46,168
XareltoRivaroxaban38$41,185
JardianceEmpagliflozin19$16,955
BrilintaTicagrelor13$16,204
OzempicSemaglutide11$14,684
Repatha SyringeEvolocumab16$10,782
Rosuvastatin Calcium416$7,310
Metoprolol Succinate260$4,522
Atorvastatin Calcium424$4,197
Ezetimibe171$3,958
Valsartan41$3,822
Nebivolol Hcl35$3,451

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$29$72,27657 claims
Johnson & JohnsonXarelto$15$41,18538 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 10th percentile of 303 interventional cardiology providers in Illinois.

Other interventional cardiology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →